Genetically Modified Mesenchymal Stromal/Stem Cells: Application in Critical Illness
Author:
Publisher
Springer Science and Business Media LLC
Link
https://link.springer.com/content/pdf/10.1007/s12015-020-10000-1.pdf
Reference153 articles.
1. Umegaki, T., Ikai, H., & Imanaka, Y. (2011, 27). The impact of acute organ dysfunction on patients’ mortality with severe sepsis. Journal of Anaesthesiology Clinical Pharmacology, (2), 180–184. https://doi.org/10.4103/0970-9185.81816 PubMed PMID: 21772676; PubMed Central PMCID: PMCPMC3127295.
2. Terblanche, M., Kruger, P., di Gangi, S., Gearay, S., Gilfeather, L., Ferguson, N. D., et al. (2012). Risk factors for acute organ failure in intensive care unit patients who receive respiratory support in the absence of non-respiratory organ failure: An international prospective cohort study. Critical Care, 16(2), R61. https://doi.org/10.1186/cc11306 PubMed PMID: 22512834; PubMed Central PMCID: PMCPMC3681390.
3. Kaneki, M. (2017). Metabolic inflammatory complex in sepsis: Septic cachexia as a novel potential therapeutic target. Shock, 48(6), 600–609. https://doi.org/10.1097/SHK.0000000000000906.
4. Rossaint, J., & Zarbock, A. (2015). Pathogenesis of multiple organ failure in sepsis. Critical Reviews in Immunology, 35(4), 277–291.
5. Shankar-Hari, M., Phillips, G. S., Levy, M. L., Seymour, C. W., Liu, V. X., Deutschman, C. S., et al. (2016). Developing a new definition and assessing new clinical criteria for septic shock: For the third International consensus definitions for sepsis and septic shock (sepsis-3). JAMA, 315(8), 775–787. https://doi.org/10.1001/jama.2016.0289 PubMed PMID: 26903336; PubMed Central PMCID: PMCPMC4910392.
Cited by 27 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. The MSC-EV-microRNAome: A Perspective on Therapeutic Mechanisms of Action in Sepsis and ARDS;Cells;2024-01-09
2. Implications of stem cell therapy on the socio-scientific community;Stem Cells;2024
3. Increasing β-hexosaminidase A activity using genetically modified mesenchymal stem cells;Neural Regeneration Research;2024-01
4. Review of research progress on the role of the effective components of traditional Chinese medicine in sepsis with multiple organ dysfunction;Heliyon;2023-11
5. Network-Based In Silico Analysis of New Combinations of Modern Drug Targets with Methotrexate for Response-Based Treatment of Rheumatoid Arthritis;Journal of Personalized Medicine;2023-10-29
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3